Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Novel pharmacological approaches for treating tobacco dependence and withdrawal: current status.

Buchhalter AR, Fant RV, Henningfield JE.

Drugs. 2008;68(8):1067-88. Review.

PMID:
18484799
2.

Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.

Frishman WH.

Prev Cardiol. 2007 Spring;10(2 Suppl 1):10-22. Review.

3.

Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.

Henningfield JE, Shiffman S, Ferguson SG, Gritz ER.

Pharmacol Ther. 2009 Jul;123(1):1-16. doi: 10.1016/j.pharmthera.2009.03.011. Review.

4.

Effects of methoxsalen, a CYP2A5/6 inhibitor, on nicotine dependence behaviors in mice.

Bagdas D, Muldoon PP, Zhu AZ, Tyndale RF, Damaj MI.

Neuropharmacology. 2014 Oct;85:67-72. doi: 10.1016/j.neuropharm.2014.05.006.

5.

[New possibilities in pharmacological treatment of nicotine dependence].

Hildebrand BE, Svensson TH.

Lakartidningen. 1999 Nov 24;96(47):5217-22, 5224. Review. Swedish.

PMID:
10608113
6.

Current and emerging pharmacotherapies for treating tobacco dependence.

Schnoll RA, Lerman C.

Expert Opin Emerg Drugs. 2006 Sep;11(3):429-44. Review.

PMID:
16939383
7.
8.

Pharmacotherapy for tobacco dependence.

Fant RV, Buchhalter AR, Buchman AC, Henningfield JE.

Handb Exp Pharmacol. 2009;(192):487-510. doi: 10.1007/978-3-540-69248-5_17. Review.

PMID:
19184660
9.

Decreasing smoking behaviour and risk through CYP2A6 inhibition.

Sellers EM, Tyndale RF, Fernandes LC.

Drug Discov Today. 2003 Jun 1;8(11):487-93. Review.

PMID:
12818518
10.

An update on therapeutics for tobacco dependence.

Lancaster T, Stead L, Cahill K.

Expert Opin Pharmacother. 2008 Jan;9(1):15-22. Review.

PMID:
18076335
11.

Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies.

Le Foll B, Forget B, Aubin HJ, Goldberg SR.

Addict Biol. 2008 Jun;13(2):239-52. doi: 10.1111/j.1369-1600.2008.00113.x. Review.

12.

Rimonabant for treating tobacco dependence.

Steinberg MB, Foulds J.

Vasc Health Risk Manag. 2007;3(3):307-11. Review.

13.

Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.

Benowitz NL.

Clin Pharmacol Ther. 2008 Apr;83(4):531-41. doi: 10.1038/clpt.2008.3. Review.

PMID:
18305452
14.

Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.

Malaiyandi V, Sellers EM, Tyndale RF.

Clin Pharmacol Ther. 2005 Mar;77(3):145-58. Review.

PMID:
15735609
15.

CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.

Kubota T, Nakajima-Taniguchi C, Fukuda T, Funamoto M, Maeda M, Tange E, Ueki R, Kawashima K, Hara H, Fujio Y, Azuma J.

Pharmacogenomics J. 2006 Mar-Apr;6(2):115-9.

PMID:
16402086
16.

Neural bases of pharmacological treatment of nicotine dependence - insights from functional brain imaging: a systematic review.

Menossi HS, Goudriaan AE, de Azevedo-Marques Périco C, Nicastri S, de Andrade AG, D'Elia G, Li CS, Castaldelli-Maia JM.

CNS Drugs. 2013 Nov;27(11):921-41. doi: 10.1007/s40263-013-0092-8. Review.

PMID:
23853032
17.

New medications for nicotine dependence treatment.

Hurt RD.

Nicotine Tob Res. 1999;1 Suppl 2:S175-9; discussion S207-10. Review.

PMID:
11768177
18.

Current pharmacological treatments for nicotine dependence.

George TP, O'Malley SS.

Trends Pharmacol Sci. 2004 Jan;25(1):42-8. Review.

PMID:
14723978
19.

Involvement of glutamatergic and GABAergic systems in nicotine dependence: Implications for novel pharmacotherapies for smoking cessation.

Li X, Semenova S, D'Souza MS, Stoker AK, Markou A.

Neuropharmacology. 2014 Jan;76 Pt B:554-65. doi: 10.1016/j.neuropharm.2013.05.042. Review.

20.

[Clonidine in the treatment of tobacco withdrawal. A comparison with nicotine chewing gum].

Aparici M, Fernández González AL, Alegría E.

Rev Clin Esp. 1994 Jun;194(6):453-6. Spanish.

PMID:
8079014
Items per page

Supplemental Content

Support Center